R D Trends Parkinson s Disease Pipeline swells but a paradigm shift is unlikely in the mid term

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Intracranial Hypertension Global Clinical Trials Review, H2, 2014

Intracranial Hypertension Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • July 2014
  • 57 pages

Intracranial Hypertension Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Intracranial Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Intracranial Hypertension clinical trial scenario. This report provides elemental information and data ...

Industries: Drug Discovery and Development | Countries: World, United States

Neonatal Seizures Global Clinical Trials Review, H2, 2014

Neonatal Seizures Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • July 2014
  • 52 pages

Neonatal Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical ...

Industries: Drug Discovery and Development | Countries: World, United States

Partial Seizure Global Clinical Trials Review, H2, 2014

Partial Seizure Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • July 2014
  • 181 pages

Partial Seizure Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Partial Seizure Global Clinical Trials Review, H2, 2014" provides data on the Partial Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials ...

Industries: Drug Discovery and Development | Countries: World, United States

Akron Molecules AG - Product Pipeline Review - 2014

Akron Molecules AG - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • by Global Markets Direct
  • June 2014
  • 28 pages

Akron Molecules AG - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Akron Molecules AG - Product Pipeline Review - 2014', provides an overview of the Akron Molecules AG's pharmaceutical research and development focus. This report provides comprehensive information on the current ...

Industries: Drug Discovery and Development | Countries: United States

Retinal Degeneration - Pipeline Review, H1 2014

Retinal Degeneration - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • June 2014
  • 55 pages

Retinal Degeneration - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Retinal Degeneration - Pipeline Review, H1 2014', provides an overview of the Retinal Degeneration's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Retinal Degeneration, ...

Industries: Drug Discovery and Development | Countries: World, United States

Sedation - Pipeline Review, H1 2014

Sedation - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • June 2014
  • 58 pages

Sedation - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Sedation - Pipeline Review, H1 2014', provides an overview of the Sedation's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sedation, complete with comparative analysis at ...

Industries: Drug Discovery and Development | Countries: World, United States

Dysthymia Global Clinical Trials Review, H1, 2014

Dysthymia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • June 2014
  • 66 pages

Dysthymia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Dysthymia Global Clinical Trials Review, H1, 2014" provides data on the Dysthymia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dysthymia. ...

Industries: Drug Discovery and Development | Countries: World, United States

Phobia Global Clinical Trials Review, H1, 2014

Phobia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • June 2014
  • 82 pages

Phobia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Phobia Global Clinical Trials Review, H1, 2014" provides data on the Phobia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Phobia It includes ...

Industries: Drug Discovery and Development | Countries: World, United States

Meridian Bioscience, Inc. (VIVO) - Product Pipeline Analysis, 2014 Update

Meridian Bioscience, Inc. (VIVO) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • June 2014
  • 38 pages

Summary Meridian Bioscience, Inc. (Meridian) is a fully integrated life science company. It develops, manufactures, sells, and distributes diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures and distributes bulk antigens, antibodies, ...

Industries: Drug Discovery and Development | Countries: United States, Singapore

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2014

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • June 2014
  • 80 pages

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2014', provides an overview of the Alpha- Antitrypsin Deficiency's therapeutic pipeline. This report provides comprehensive information on the therapeutic development ...

Industries: Drug Discovery and Development | Countries: World, United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.